PLoS ONE · 2009 · 136 citations · 52 references
Life SciencesCell BiologyImmunologyAdaptive ImmunityCell SignalingDevelopmental ImmunologyAdaptive Immune ResponsesB Cell BiologyB Cell DevelopmentB Cell RegulationHumoral ImmunityLymphocyte DevelopmentAntibody-dependent Cell-mediated CytotoxicityAntibody-dependent Cellular CytotoxicityB-1 CellsComplement-mediated Cell LysisFollicular B CellsMarginal Zone B Cell DevelopmentMarginal Zone B CellsSignaling
Defects in the expression of either BAFF (B cell activating factor) or BAFF-R impairs B cell development beyond the immature, transitional type-1 stage and thus, prevents the formation of follicular and marginal zone B cells, whereas B-1 B cells remain unaffected. The expression of BAFF-R on all mature B cells might suggest a role for BAFF-R signaling also for their in vivo maintenance. Here, we show that, 14 days following a single injection of an anti-BAFF-R mAb that prevents BAFF binding, both follicular and marginal zone B cell numbers are drastically reduced, whereas B-1 cells are not affected. Injection of control, isotype-matched but non-blocking anti-BAFF-R mAbs does not result in B cell depletion. We also show that this depletion is neither due to antibody-dependent cellular cytotoxicity nor to complement-mediated lysis. Moreover, prevention of BAFF binding leads to a decrease in the size of the B cell follicles, an impairment of a T cell dependent humoral immune response and a reduction in the formation of memory B cells. Collectively, these results establish a central role for BAFF-BAFF-R signaling in the in vivo survival and maintenance of both follicular and marginal zone B cell pools.
52
Activation by IKKα of a Second, Evolutionary Conserved, NF-κB Signaling Pathway
Uwe Senftleben, Yixue Cao, Gutian Xiao et al. · Science · 2001 · 1.4K citations
TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease
Jane A. Gross, Janet Johnston, Sherri Mudri et al. · Nature · 2000 · 1.2K citations